Expertise in
6
conditions

Mutsushi Kawakita

Kobe, JP 
Expertise in
6
conditions
Kobe, JP 

Overview

Mutsushi Kawakita practices practicing medicine in Kobe, Japan.

Kawakita is highly rated in 6 conditions, according to our data. Their clinical expertise encompasses Renal Cell Carcinoma (RCC), Bladder Cancer, Prostate Cancer, Nephrectomy, and Prostatectomy.

They are actively involved in clinical research, co-authoring 94 peer reviewed articles and participating in 2 clinical trials.

Locations

Kobe, 6500047, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib in Patients With Metastatic Castration-Resistant Prostate Cancer
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib in Patients With Metastatic Castration-Resistant Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: August 07, 2026
Intervention Type: Drug
Study Drugs: Abemaciclib, Abiraterone Acetate, Prednisone
Study Phase: Phase 2/Phase 3
CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination With Abiraterone Plus Prednisone in Men With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination With Abiraterone Plus Prednisone in Men With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 01, 2026
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

94 Total Publications

A CASE OF RENAL CELL CARCINOMA IN THE KIDNEY ALLOGRAFT 16 YEARS AFTER RENAL TRANSPLANTATION
A CASE OF RENAL CELL CARCINOMA IN THE KIDNEY ALLOGRAFT 16 YEARS AFTER RENAL TRANSPLANTATION
Journal: Hinyokika kiyo. Acta urologica Japonica
Published: September 04, 2026

Frequently Asked Questions about Mutsushi Kawakita

Is Mutsushi Kawakita a top-rated expert for Nephrectomy?

MediFind is an objective health platform that identifies experts based on real-world data. Mutsushi Kawakita is classified as an Advanced expert for Nephrectomy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Mutsushi Kawakita participate in research or clinical trials?

Yes. Mutsushi Kawakita has published 94 articles and abstracts on conditions like Nephrectomy. You can view a list of Mutsushi Kawakita's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Kawakita's expertise for a condition
ConditionClose
      View All 23 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile